JOHN MOORE: Open Payments
NPI 1255542361 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,306 in 76 payments from 13 companies in 2025. Trend: 2023 $1,271 · 2024 $1,435 · 2025 $1,306
Food & beverage: $1,306
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $324 |
| PFIZER INC. | 17 | $291 |
| Novo Nordisk Inc | 12 | $171 |
| Amgen Inc. | 12 | $136 |
| Boston Scientific Corporation | 3 | $72 |
| GlaxoSmithKline, LLC. | 4 | $61 |
| Dexcom, Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| SANOFI-AVENTIS U.S. LLC | 2 | $45 |
| Inari Medical, Inc. | 1 | $45 |
Products named: UBRELVY, ELIQUIS, NURTEC ODT, EVENITY, QULIPTA, Wegovy, Ozempic, VRAYLAR.
Industry payments across GA — which companies pay providers there.
